The Role of Lymphadenectomy in the Surgical Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Cancers · 13.12.2024 · 16 (24) · 4166
DOI: 10.3390/cancers16244166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 13.12.2024. Verfasst von Gabriele Spoletini und 7 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery and Liver Transplantation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lymphadenectomy in the operative management of hepatocellular carcinoma (HCC) remains controversial, with no recommendation for routine practice. Our study aimed to assess the effects of lymphadenectomy in addition to hepatic resection (HR) compared to HR alone for adults with HCC.
Methods
This systematic review was conducted according to PRISMA guidelines until March 2023, searching and selecting the relevant literature comparing lymph node dissection or sampling, combined with HR, and with no lymph node removal. Critical appraisal of the included studies was performed using the ROBINS-I tool. Fixed- or random-effect meta-analysis models were carried out, and inter-studies were assessed for heterogeneity.
Results
Fourteen studies were selected during the screening process. Data from eight studies containing 32,041 HCC patients were included in the quantitative synthesis. In total, 12,694 patients underwent lymph node dissection (LND), either selectively for preoperatively diagnosed or intraoperatively suspected lymph node metastasis (LNM) or unselectively (i.e., regardless of suspected LNM). According to LN status, 1-, 3- and 5-year mortality rates were higher in the LNM group with respect to both clinically negative LN (OR 3.25, 95% CI 2.52–4.21; p < 0.001; OR 3.79, 95% CI 2.74–5.24; p < 0.001; OR 3.92, 95% CI 2.61–5.88; p < 0.001) and proven LN0 (OR 1.75, 95% CI 1.0–3.04; p = 0.05; OR 2.88, 95% CI 1.79–4.63; p < 0.001; OR 2.54, 95% CI 1.33–4.84; p < 0.001). Moreover, the summary estimates of two controlled trials showed no significant difference in overall survival between LND groups and those without LND for negative LN patients.
Conclusions
Lymph node dissection does not appear to improve overall survival, according to the available literature; thus, this does not support its routine adoption as part of standard liver resection for HCC. A case-by-case decision remains advisable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Surgery and Liver Transplantation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
- Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.
ORCID-Profile: Gabriele Spoletini, Miriam Caimano, Giuseppe Bianco
Zitieren
APA
Spoletini, G., Mauro, A., Caimano, M., Marrone, G., Frongillo, F., Agnes, S., Lai, Q., & Bianco, G. (2024). The Role of Lymphadenectomy in the Surgical Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers, 16(24), 4166. https://doi.org/10.3390/cancers16244166
Vancouver
Spoletini G, Mauro A, Caimano M, Marrone G, Frongillo F, Agnes S, et al. The Role of Lymphadenectomy in the Surgical Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers. 2024;16(24):4166. doi:10.3390/cancers16244166
BibTeX
@article{Spoletini2024,
author = {Spoletini, Gabriele and Mauro, Alberto and Caimano, Miriam and Marrone, Giuseppe and Frongillo, Francesco and Agnes, Salvatore and Lai, Quirino and Bianco, Giuseppe},
title = {The Role of Lymphadenectomy in the Surgical Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis},
journal = {Cancers},
year = {2024},
volume = {16},
number = {24},
pages = {4166},
doi = {10.3390/cancers16244166}
}
EUVIMED